Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
Open Access
- 1 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 137 (1), 93-100
- https://doi.org/10.1309/ajcp59uorcyzevqo
Abstract
The membrane glycoprotein MRC OX-2 (CD200) is expressed in several lymphoid malignancies. However, the diagnostic usefulness and potential prognostic importance of CD200 expression have not been rigorously examined. We show that CD200 is uniformly expressed in chronic lymphocytic leukemia (CLL) and absent in mantle cell lymphoma (MCL). It is important to note that expression of CD200 is retained even in CLLs with immunophenotypic aberrancies, making CD200 a particularly useful marker for discrimination between these cases and MCL. CD200 is expressed in nearly all precursor B-lymphoblastic leukemias, with aberrant overexpression or underexpression compared with normal B-cell progenitors in 55% of cases. More than 70% of plasma cell myelomas (PCMs) expressed CD200, and loss of CD200 expression in PCM may be associated with more clinically aggressive disease. CD200 is expressed in several hematolymphoid neoplasms. Analysis of its expression has several diagnostic and potentially prognostic applications in the flow cytometric evaluation of lymphoid malignancies.Keywords
This publication has 35 references indexed in Scilit:
- CD200 (OX-2 Membrane Glycoprotein) Expression in B Cell–Derived NeoplasmsAmerican Journal of Clinical Pathology, 2010
- Characterization of Immunophenotypic Aberrancies in 200 Cases of B Acute Lymphoblastic LeukemiaAmerican Journal of Clinical Pathology, 2009
- The molecular characterization and clinical management of multiple myeloma in the post-genome eraLeukemia, 2009
- Small B-Cell Neoplasms With Typical Mantle Cell Lymphoma Immunophenotypes Often Include Chronic Lymphocytic LeukemiasAmerican Journal of Clinical Pathology, 2009
- CD200 as a prognostic factor in acute myeloid leukaemiaLeukemia, 2007
- A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1Blood, 2006
- The molecular classification of multiple myelomaBlood, 2006
- Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantationBlood, 2006
- Value of CD23 Determination by Flow Cytometry in Differentiating Mantle Cell Lymphoma From Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaAmerican Journal of Clinical Pathology, 2001
- Morphologically Typical and Atypical B-Cell Chronic Lymphocytic Leukemias Display a Different Pattern of Surface Antigenic DensityLeukemia & Lymphoma, 2001